Guidelines
VIEW:
GUIDELINES
ICOP-Pharm: could the new paradigm bridge a gap in evidence raised by 2022 ESC guidelines on cardio-oncology?
March 28, 2024
PHARMACY
GUIDELINES
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis
March 28, 2024
AMYLOIDOSIS
GUIDELINES
Clinical Practice and Research in Cardio-Oncology: Finding the “Rosetta Stone” for Establishing Program Excellence in Cardio-oncology
March 28, 2024
CLINCAL PRACTICE
GUIDELINES
Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel
March 24, 2024
CARDIAC DISEASE
GUIDELINES
Prevention, Diagnosis, and Management of Radiation-Associated Cardiac Disease: JACC Scientific Expert Panel
March 24, 2024
CARDIAC DISEASE
GUIDELINES
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS): Developed by the task force on cardio-on
November 1, 2022
CARDIO-ONCOLOGHY GUIDELINE
GUIDELINES
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
December 5, 2016
CARDIAC DYSFUNCTION IN SURVIVORS OF ADULT CANCERS
GUIDELINES
SMO Clinical Practice Guidelines†
October 1, 2012
IMAGING
Get Certified
See All CertificationsAdvance Your Cardio-Oncology Knowledge- Working Groups |
- Research Working Group
- Working Groups |
- Advocacy
- •
- Amyloidosis
- •
- Centers of Excellence
- •
- Imaging
- •
- Pediatrics
- •
- Survivorship
